Study of adults with chronic hepatitis B in Korea
Part of Digestive system, Infections clinical trials.
This study follows adults with long-term hepatitis B to better understand their health over time and improve care. If you have chronic hepatitis B and can do regular check-ins, you may be invited to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 19 years
- Have chronic hepatitis B (tested positive for hepatitis B surface protein, HBsAg, for more than 6 months)
- Have been getting regular medical follow-up for hepatitis B
- Be able to attend follow-up visits as the study schedule requires
- Provide written consent (you or your guardian)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how patients with chronic hepatitis B are managed when they visit non-liver clinics. It aims to improve care and may also include a survey about quality of life for those starting treatment.
This study looks at long-term outcomes in people with chronic hepatitis B who take antiviral medicines or receive interferon. It may help doctors understand which treatments work best over time and who is most likely to benefit.
This study tests whether a smartphone app called HBVCare helps patients with chronic hepatitis B stick to their treatment plans. Researchers will track how well the app helps patients take their medicines on time and understand what makes treatment adherence easier or harder.
This trial is for people with chronic hepatitis B who have already cleared the virus with interferon treatment. It tests ongoing strategies to help maintain their health and prevent the virus from coming back.
This study follows participants with chronic hepatitis B who previously responded to the drug AHB-137. The goal is to track long-term health and safety after their treatment.
This study looks at adults with chronic hepatitis B who have achieved a cure (HBsAg negative). It aims to understand the best treatment priorities and cost-effectiveness using real-world data.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.